News
Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...
After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...
5d
TipRanks on MSNAbbVie’s Promising Phase 3 Study on Upadacitinib for Alopecia AreataAbbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...
Eric Charbonneau/Warner Bros. via Getty ImagesAnthony Carrigan is opening up about the deeply personal connection he has to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results